Up next

Autoplay

MRD Monitoring in Acute Lymphoblastic Leukemia

0 Views • 06/15/23
Share
Embed
administrator
administrator
Subscribers
0

In this segment, Raoul Tibes, MD, PhD, discusses risk stratification based on minimal residual disease monitoring in patients with acute lymphoblastic leukemia achieve remission.

Show more
0 Comments sort Sort By
Facebook Comments

Up next

Autoplay